Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
posted on
Mar 30, 2020 12:10PM
What I find frustrating the if we saw omproved eGFR with patients below 60 subgroup.
It was not in this publication and IR won't tell us if/when we will see it,...